John Doe

UBS Chair Colm Kelleher said that the Swiss government’s proposal to require the bank to hold substantially more capital is the “wrong remedy” to the failings […]

Hedge fund Appaloosa LP became the latest to sue over the $17 billion wipeout of high-risk bonds last year that was part of the deal to […]

Change is afoot in the upper echelons of Novartis, with Giovanni Caforio set to be elected as the next chair of its board of directors at […]

Zolgensma, a one-off treatment for infants born with a rare and often fatal genetic disease, came to the market five years ago at an eye-watering $2.1 […]